S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
BREAKING: Tiny biotech successfully treats blindness (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Urgent Warning (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Urgent Warning (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
BREAKING: Tiny biotech successfully treats blindness (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Urgent Warning (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Urgent Warning (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
BREAKING: Tiny biotech successfully treats blindness (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Urgent Warning (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Urgent Warning (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
MarketBeat Week in Review – 3/20 - 3/24
BREAKING: Tiny biotech successfully treats blindness (Ad)
Germany, EU reach agreement in combustion engine row
Bank failures and rescue test Yellen's decades of experience
Urgent Warning (Ad)
Intel co-founder, philanthropist Gordon Moore dies at 94
'What can we do?': Millions in African countries need power
Urgent Warning (Ad)
Judge rules online archive's book service violated copyright
Renamed Horseshoe to host Poker World Series on Vegas Strip
NASDAQ:RDNT

RadNet - RDNT Stock Forecast, Price & News

$23.35
+0.21 (+0.91%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$22.70
$23.49
50-Day Range
$20.00
$25.07
52-Week Range
$12.03
$25.78
Volume
175,809 shs
Average Volume
339,084 shs
Market Capitalization
$1.35 billion
P/E Ratio
137.35
Dividend Yield
N/A
Price Target
$30.00

RadNet MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
28.5% Upside
$30.00 Price Target
Short Interest
Healthy
2.58% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.52
Upright™ Environmental Score
News Sentiment
0.52mentions of RadNet in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
35.29%
From $0.34 to $0.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Medical Sector

75th out of 1,005 stocks

Medical Laboratories Industry

2nd out of 26 stocks


RDNT stock logo

About RadNet (NASDAQ:RDNT) Stock

RadNet, Inc. provides freestanding, fixed-site outpatient diagnostic imaging services in the United States. Its centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders and reduce unnecessary invasive procedures. The firm offers magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures. RadNet was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.

Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
Are Investors Undervaluing RadNet (RDNT) Right Now?
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
RadNet (RDNT) Misses Q4 Earnings Estimates
RadNet Stock Gaps Down On Today's Open (RDNT)
Is RadNet, Inc.'s (NASDAQ:RDNT) ROE Of 6.5% Concerning?
RadNet (RDNT) Misses Q3 Earnings and Revenue Estimates
See More Headlines
Receive RDNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RadNet and its competitors with MarketBeat's FREE daily newsletter.

RDNT Company Calendar

Last Earnings
2/28/2023
Today
3/25/2023
Next Earnings (Estimated)
5/08/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medical laboratories
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:RDNT
Employees
9,067
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$30.00
High Stock Price Forecast
$30.00
Low Stock Price Forecast
$30.00
Forecasted Upside/Downside
+28.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$10.65 million
Pretax Margin
3.00%

Debt

Sales & Book Value

Annual Sales
$1.43 billion
Cash Flow
$3.55 per share
Book Value
$8.57 per share

Miscellaneous

Free Float
54,886,000
Market Cap
$1.35 billion
Optionable
Optionable
Beta
1.55

Social Links


Key Executives

  • Howard G. Berger
    Chairman, Co-President & Chief Executive Officer
  • Norman R. HamesNorman R. Hames
    Co-President & COO-Western Operations
  • Stephen M. Forthuber
    Co-President & COO-Eastern Operations
  • Mark D. Stolper
    Chief Financial Officer & Executive Vice President
  • John V. Crues
    Medical Director & Vice President













RDNT Stock - Frequently Asked Questions

Should I buy or sell RadNet stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for RadNet in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" RDNT shares.
View RDNT analyst ratings
or view top-rated stocks.

What is RadNet's stock price forecast for 2023?

1 analysts have issued 12 month price targets for RadNet's shares. Their RDNT share price forecasts range from $30.00 to $30.00. On average, they anticipate the company's share price to reach $30.00 in the next year. This suggests a possible upside of 28.5% from the stock's current price.
View analysts price targets for RDNT
or view top-rated stocks among Wall Street analysts.

How have RDNT shares performed in 2023?

RadNet's stock was trading at $18.83 at the beginning of 2023. Since then, RDNT shares have increased by 24.0% and is now trading at $23.35.
View the best growth stocks for 2023 here
.

When is RadNet's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, May 8th 2023.
View our RDNT earnings forecast
.

How were RadNet's earnings last quarter?

RadNet, Inc. (NASDAQ:RDNT) announced its earnings results on Tuesday, February, 28th. The medical research company reported $0.11 earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by $0.08. The medical research company had revenue of $383.90 million for the quarter, compared to analyst estimates of $347.27 million. RadNet had a trailing twelve-month return on equity of 2.64% and a net margin of 0.74%. RadNet's revenue for the quarter was up 15.3% on a year-over-year basis. During the same period in the prior year, the firm earned $0.13 earnings per share.

What guidance has RadNet issued on next quarter's earnings?

RadNet updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.54 billion-$1.59 billion, compared to the consensus revenue estimate of $1.46 billion.

What is Howard G. Berger's approval rating as RadNet's CEO?

174 employees have rated RadNet Chief Executive Officer Howard G. Berger on Glassdoor.com. Howard G. Berger has an approval rating of 45% among the company's employees. This puts Howard G. Berger in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of RadNet own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RadNet investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), OPKO Health (OPK), Boeing (BA), Rigel Pharmaceuticals (RIGL), UnitedHealth Group (UNH), Pfizer (PFE) and AT&T (T).

What is RadNet's stock symbol?

RadNet trades on the NASDAQ under the ticker symbol "RDNT."

Who are RadNet's major shareholders?

RadNet's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Beck Mack & Oliver LLC (5.60%), Edmond DE Rothschild Holding S.A. (4.46%), Dimensional Fund Advisors LP (2.68%), Global Alpha Capital Management Ltd. (2.65%), Geode Capital Management LLC (1.63%) and Silvercrest Asset Management Group LLC (1.19%). Insiders that own company stock include Christine Nayoma Gordon, David L Swartz, John V Crues, Lawrence L Levitt, Lawrence L Levitt, Michael N Murdock, Norman R Hames and Ruth Louisa Villigerwilson.
View institutional ownership trends
.

How do I buy shares of RadNet?

Shares of RDNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is RadNet's stock price today?

One share of RDNT stock can currently be purchased for approximately $23.35.

How much money does RadNet make?

RadNet (NASDAQ:RDNT) has a market capitalization of $1.35 billion and generates $1.43 billion in revenue each year. The medical research company earns $10.65 million in net income (profit) each year or $0.17 on an earnings per share basis.

How many employees does RadNet have?

The company employs 9,067 workers across the globe.

How can I contact RadNet?

RadNet's mailing address is 1510 COTNER AVE, LOS ANGELES CA, 90025. The official website for the company is www.radnet.com. The medical research company can be reached via phone at (310) 445-2800, via email at investorrelations@radnet.com, or via fax at 310-445-2980.

This page (NASDAQ:RDNT) was last updated on 3/25/2023 by MarketBeat.com Staff